1. A small-molecule probe for monitoring binding to prolyl hydroxylase domain 2 by fluorescence polarisation. Issue 91 (28th October 2020) Authors: Li, Zhihong; Zhen, Shuai; Su, Kaijun; Tumber, Anthony; Yu, Quanwei; Dong, Ying; McDonough, Michael; Schofield, Christopher J.; Zhang, Xiaojin Journal: Chemical communications Issue: Volume 56:Issue 91(2020) Page Start: 14199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Allosteric inhibition of HIF-2α as a novel therapy for clear cell renal cell carcinoma. Issue 12 (December 2019) Authors: Yu, Yancheng; Yu, Quanwei; Zhang, Xiaojin Journal: Drug discovery today Issue: Volume 24:Issue 12(2019) Page Start: 2332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Discovery of prolyl hydroxylase 2 inhibitors with new chemical scaffolds as in vivo active erythropoietin inducers through a combined virtual screening strategy. (7th November 2019) Authors: Yu, Zhan; Li, Zhihong; Yu, Quanwei; Wang, Zhi; Song, Huilin; Sun, Hanyu; Fan, Rufeng; Bi, Angzhi; Zhang, Jun; Zhang, Xiaojin Journal: Chemical biology & drug design Issue: Volume 95:Number 2(2020) Page Start: 270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗